Novartis2d
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting
Basel, March 7, 2025 – Novartis shareholders today agreed to the Board of Directors’ recommendations for all proposed resolutions at the company’s Annual General Meeting (AGM). A total of 1,693 ...
Novartis8d
Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)
About Fabhalta® (iptacopan) Fabhalta (iptacopan) is an oral, Factor B inhibitor of the alternative complement pathway 6-7.
Novartis16h
Career search
Job Title Sort ascending Business Location Site Date Posted （高级）区域市场经理 Regular, Full time Innovative Medicines China Hangzhou (Zhejiang Province) Mar 07, 2025 Analyst, Digital Regular, Full time ...
Novartis2d
Career Search
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Novartis6d
India Site Locations
7th Floor, Bandra-Kurla Complex, ...
Novartis6d
Patients and caregivers
Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Our significant investment in research and development underpins our commitment to ...
Novartis16h
Zaposlitev v Novartisu v Sloveniji
V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...
Novartis16h
Offene Stellen
Manager, TA Patient Advocacy Regular, Full time CTS China Shanghai (Shanghai) März 04, 2025 Manager, TA Communications Regular, Full time CTS China Shanghai (Shanghai) März 04, 2025 ...
Novartis10h
Lediga tjänster
Bli en del av Novartis, här kan du se mer om vilka karriärmöjligheter som finns. Du kan också söka lediga tjänster hos Novartis Gene Therapies här. Automatisierungsingennieur (m/w/d) Regular, Full ...
Novartis26d
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathway Abelacimab is currently in ...
Novartis14h
Oferty pracy
Sprawdź aktualne oferty i ubiegaj się o pracę w spółkach Grupy Novartis na całym świecie.
Novartis22h
Rechercher de Carrières
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.